Avacta Group (AVCT)


Latest News

Director Deals - Avacta Group PLC (AVCT)

Dr Mike Owen, Non Executive Director, bought 7,763 shares in the company on the 21st October 2016 at a price of 90.00p. T...

Director's Dealing

RNS Number: 1878N Avacta Group PLC 21 October 2016 21 October 2016 Avacta Group plc ("Avacta", "the Group" or "the Company") Director's Dealing Avacta Group plc (AIM: AVCT), the developer of Affimer biotherapeutics, research and diagnostic reagents, announces that Dr. Mike Owen, a Non-Executive Director of the Group, has purchased today 7,763 Ordin...

Hardman Research: Great strides to strategic goals

RNS Number: 7270M Avacta Group PLC 17 October 2016 Hardman Research: Great strides towards strategic goals Great strides towards strategic goals: Avacta is the proprietary owner of Affimer technology for the development of bio-therapeutics, diagnostic tests and research reagents. Affimers represent a revolutionary alternative to the established antibody techno...

Broker Forecast - finnCap issues a broker note on Avacta Group PLC

finnCap today reaffirms its corporate investment rating on Avacta Group PLC (LON:AVCT) and set its price target at 200...

All News

21-10-16Director Deals - Avacta Group PLC (AVCT)StockMarketWire
21-10-16Director's DealingRNS
17-10-16Hardman Research: Great strides to strategic goalsRNS
17-10-16Broker Forecast - finnCap issues a broker note on Avacta Group PLCStockMarketWire
17-10-16Prelim Results for the Year Ended 31 July 2016RNS
04-10-16Issue of EquityRNS
26-09-16Notice of ResultsRNS
22-09-16Positive results from first preclinical studiesRNS
12-09-16Change of AdviserRNS
31-08-16Avacta changes registered office StockMarketWire
31-08-16Change of Registered OfficeRNS
16-08-16Avacta opens new facilities in Cambridge and WetherbyStockMarketWire
16-08-16New Facilities in Cambridge and WetherbyRNS
10-08-16Avacta gets grant funding for new diagnostic testsStockMarketWire
10-08-16Grant FundingRNS
03-08-16Avacta granted key Affimer patents in Europe and US StockMarketWire
03-08-16Key Affimer patents to be granted in Europe and USRNS
01-08-163 stocks set to soar after today’s news flow?Motley Fool
01-08-16Trading StatementRNS
19-07-16Holding(s) in CompanyRNS
19-07-16Hardman report: New Affimer opportunitiesRNS
14-07-16Collaboration with GlytheraRNS
08-07-16Director/PDMR ShareholdingRNS
22-06-16Avacta generates Affimer binders for Zika virus StockMarketWire
22-06-16Affimer Binders for Zika Virus DiagnosticsRNS
16-06-16Issue of EquityRNS
13-06-16Avacta collaborationStockMarketWire
13-06-16Collaboration with MologicRNS
29-04-16Director Deals - Avacta Group PLC (AVCT)StockMarketWire
29-04-16Director's DealingRNS
25-04-16Broker Forecast - Numis issues a broker note on Avacta Group PLCStockMarketWire
25-04-16Avacta revenues rise StockMarketWire
25-04-16Half-year ReportRNS
19-04-16Avacta achieves development milestone StockMarketWire
19-04-16Affimer Therapeutic Platform Development MilestoneRNS
07-04-16Director's DealingRNS
05-04-16Investor EveningRNS
24-03-16Should you buy shares worth less than 1p?Interactive Investor
15-03-16Issue of EquityRNS
07-03-16Avacta establishes scientific advisory boardStockMarketWire

RSS feeds

  • Editorial news feed for LSE:AVCT Editorial
  • Regulatory news feed for LSE:AVCT Regulatory